baber/WOPTO huggingface dataset:
Patent DE-602005004693-T2 (DE)
Inventor: SHUM HEUNG-YEUNG
IPC: G06T1/00
Filed: 2005-03-18
Granted: 2009-02-12
Abstract: A radiometric calibration system finds an inverse response function of a camera from a single digital image of a scene in which the actual colors of the scene are not known  a priori . The system analyzes pixels of the image that correspond to an "edge" between two colors of the scene. These "edge" pixels represent a blended color formed from these two "component" colors, as measured by the camera. The system determines an inverse response function at least in part by: (a) finding suitable edge pixels; and (b) determining a function that maps the measured blended colors of edge pixels and their measured component colors into linear distributions. Reference data that includes predetermined inverse response functions of known cameras can be used in determining an inverse response function via a Bayesian Estimation.
Patent DE-602005005889-T2 (DE)
Inventor: FERRARI MAURIZIO
IPC: B23Q11/00
Filed: 2005-04-14
Granted: 2009-05-07
Abstract: A toolhead (1) for use on a multi-axis machine tool consists of a support assembly (2) equipped with a pivoting spindle (3) designed to accept a removable tool-holder (4), and centred on a machining axis (J) about which a tool (U) clamped to the tool-holder (4) can be driven in rotation. Also forming part of the toolhead (1) is a depth stop (9) affording an active surface (10) substantially transverse to the machining axis (J) and positionable against a surface (S) of a workpiece (P). The depth stop (9) is mounted to the support assembly (2) and capable of movement along the machining axis (J) between a first position, distanced from the spindle (3), and a second position of proximity to the spindle (3). Transducers (12) incorporated into the toolhead (1) are able to sense the position of the active surface (10) relative to the support assembly (2), and thus used to control the depth to which the workpiece (P) is penetrated by the tool (U). <IMAGE>
Patent DE-60119941-T3 (DE)
Inventor: FOODY BRIAN
IPC: C12P19/14
Filed: 2001-09-25
Granted: 2017-11-16
Abstract: The present invention pertains to a method of converting cellulose to glucose by treating a pretreated lignocellulosic substrate with an enzyme mixture comprising cellulase enzyme and a modified CBHO, wherein the modified CBHI is present in the enzyme mixture at an amount relative to all CBHI-type enzymes from about 15% to about 100% (w/w),depending upon the modified CBHI used. The pretreated lignocellulosic substrate is selected from the group consisting of agricultural residues, residues after starch or sugar removal dedicated ethanol crops forestry products, and pulp and paper products, or combinations thereof.
Patent DE-60202740-T3 (DE)
Inventor: KAWANISHI SHINJI
IPC: F04D29/64
Filed: 2002-11-05
Granted: 2011-02-10
Abstract: The present invention provides a vacuum pump in which a damaging torque produced when a rotating rotor (6) crashes into the inner wall of a pump case (1), is prevented to transfer to a vacuum chamber (200) so as to protect the vacuum chamber. Bolt-holes of flange portions (1a), through which the vacuum pump (100) and the vacuum chamber and also the pump case and a base member (4) disposed below the pump case are fastened, respectively, are formed so as to have larger diameters than the shank diameters of corresponding bolts by 20% or more. With this arrangement, when the entire vacuum turns moved by the damaging torque, the pump case slips relative to the vacuum chamber and the base member by the gaps between the pump case-base member fastening bolt-holes and the pump case-base member fastening bolts. As a result, the damaging torque is absorbed and is prevented to transfer to the vacuum chamber. <IMAGE>
Patent DE-69025933-T3 (DE)
Inventor: KLIGERMAN ALAN
IPC: A23L1/305
Filed: 1990-05-10
Granted: 2002-09-05
Abstract: A composition is provided for ingestion by mammals for in vivo conversion of alpha-D-galactoside comprising an amount of alpha-galactosidase effective to hydrolyze alpha-D-galactoside to D-galactose, and non-toxic, ingestible excipients(s) for said alpha-galactrosidase. Gastric distress in mammals due to ingestion of foods containing alpha-D-galactoside may be reduced by ingesting the foregoing composition of alpha-galactosidase and non-toxic, ingestible excipient contemporaneously with the ingestion of said food in an amount effective to hydrolyze the alpha-D-galactoside to D-galactose.
Patent DE-69216170-T3 (DE)
Inventor: DABI SHMUEL
IPC: D04H18/02
Filed: 1992-07-24
Granted: 2004-07-08
Abstract: Novel facing materials (100) and methods for their manufacture are provided by this invention. The facing material (100) includes at least a fibrous top layer (10) for engaging bocy fluid and a generally opaque middle layer (20). A portion of the facing material (100) is disposed, preferably by piercing, through the generally opaque middle layer (20) to establish a fluid path through the generally opaque middle leayer (20). In the preferred embodiment, the facing material (100) includes a bottom layer (30) having a capillary structure for drawing the body fluid from the fibrous top layer (10). In this preferred embodiment, the fibrous top layer (10) extends through the generally opaque middle layer (20) to provide fluid communication between the fibrous top layer (10) and the bottom layer (30). These composite structures provide a clean/dry facing material that has a comfort of a textile facing and the high opacity of apertured thermoplastic films. <IMAGE>
Patent DK-1095699-T3 (DK)
Inventor: BEST BERND
IPC: B01J19/28
Filed: 2000-10-19
Granted: 2006-05-29
Abstract: Carrying out a multi-phase reaction in a continuously driven counter flow operating cylinder reactor, comprises reacting downward flowing liquid phase components with upward flowing gas phase components. The throughput of the liquid and solid phases is such that liquid phase blockage or flow film thickening can occur to unacceptable levels, so the pressure is changed when these levels are reached. The pressure change is controlled so the liquid phase build-up flows off below the blockage point or the film thickness reduces.
Patent DK-1122169-T3 (DK)
Inventor: BOSCHI ALESSANDRO
IPC: B65B9/20
Filed: 2000-01-31
Granted: 2004-03-29
Abstract: A device (1) for adjusting the transverse position of a strip (2) of packaging material on a packaging machine for producing packages containing a pourable food product, the device having a slide (12) movable crosswise with respect to the strip (2) and carrying a gripping member (14) for moving the strip transversely; and a system (3, 7, 8) for automatically adjusting the position of the slide (12) in response to signals generated by optical sensors (41, 42) for detecting respective limit positions of the strip (2). <IMAGE>
Patent DK-1171947-T3 (DK)
Inventor: CORNWALL REMI OSERI
IPC: F25B21/00
Filed: 2000-04-19
Granted: 2009-03-30
Abstract: An apparatus for performing a thermodynamic cycle comprising: a sample having a ferromagnetic phase transition temperature; means to magnetise the sample above the ferromagnetic phase transition temperature of the sample; and means to cool the sample to a temperature that is below the ferromagnetic phase transition temperature thereof, wherein the demagnetisation of the sample whilst the sample is below the ferromagnetic phase transition temperature thereof causes the generation of an independent magnetic flux. Also disclosed is a method of converting energy, comprising the steps of: providing a sample having a ferromagnetic transition temperature; magnetising the sample while the sample is above the ferromagnetic transition temperature thereof; allowing the sample to demagnetise while the sample is below the ferromagnetic transition temperature thereof, the demagnetisation of the sample causing an independent magnetic flux; and converting at least some of the independent magnetic flux into an electric current. An analogous ferroelectric apparatus and an analogous ferroelectric method are also presented.
Patent DK-1187955-T3 (DK)
Inventor: FLADER MICHAEL E
IPC: E01F9/06
Filed: 2000-05-26
Granted: 2007-05-29
Abstract: A pavement marker having improved daytime visibility comprises a transparent fluorescent top portion having smooth flat parallel top and bottom surfaces with a front edge therebetween and air interfacing most of the bottom surface. Light received by the smooth flat top surface of the top portion is directed internally through the top portion and emitted from the front edge, to provide a visible signal to drivers of oncoming vehicles.
Patent DK-1236367-T3 (DK)
Inventor: VIRKKULA PETRI
IPC: H04L29/06
Filed: 2000-12-08
Granted: 2006-06-19
Abstract: A method and system for interchanging information safely between the user and a SIM Application Toolkit application in a telecommunication system comprising a terminal device (MS), connected to a telecommunication network (WN); a smart card (SC) inserted into the terminal device (MS); a WAP client program (WAPCLIENT) and a SIM Application Toolkit (STK), arranged in the terminal device (MS) and/or the smart card (SC); and a first application (WMLSCRIPT) which is part of the WAP client program (WAPCLIENT). The terminal device (MS) comprises the necessary features for using the WAP. As part of the WAP client program (WAPCLIENT), the second application (DRIVER) is added to start and control the SIM Application Toolkit applications. The first application (WMLSCRIPT) calls the second application (DRIVER) when wishing to use SIM Application Toolkit applications. The second application (DRIVER) controls and manages the SIM Application Toolkit applications and the interchange of information between the user of the terminal device (MS) and the SIM Application Toolkit applications.
Patent DK-1347753-T3 (DK)
Inventor: WYLLIE MICHAEL G
IPC: A61K9/06
Filed: 2001-12-17
Granted: 2006-07-10
Abstract: There is provided a method and composition for treating urinary stress incontinence based upon the topical administration of an alpha-adrenoceptor agonist, such as phenylephrine. A daily dosage of 20 mg to 2000 mg is suitable, and the composition may conveniently be applied as a cream or gel to the vaginal or peri-urethral area.
Patent DK-1257562-T3 (DK)
Inventor: HANSEN MARIE BENDIX
IPC: C12N9/64
Filed: 2001-02-08
Granted: 2007-04-02
Abstract: Processes for recovering a target protein having milk clotting activity including chymosin, and other target proteins or peptides from an aqueous medium containing such a protein using a resin material comprising a solid support matrix and, covalently bound to the matrix, a target protein binding ligand selected from benzylamine or a derivative thereof; an alkylamine, an alkenylamine, an alkynylamine, an alkoxyamine and an amine of mono- or bicyclic aromatic or heteroaromatic moieties, any of which is optionally substituted with at least one group other than an acidic group. The resin material may conveniently be in a packed or a fluidised or expanded bed.
Patent DK-1283735-T3 (DK)
Inventor: DEMUTH HANS-ULRICH
IPC: A61P37/06
Filed: 2001-04-02
Granted: 2009-04-06
Abstract: The present invention discloses a method for therapeutically treating mammals, including but not limited to humans, to increase the relative insulin producing performance of endogenous pancreatic ²-cells and to cause differentiation of pancreatic epithelial cells into insulin producing ²-cells. Oral administration of a DP IV inhibitor causes the active form of GLP-1 to be preserved longer under physiological conditions. The extended presence of GLP-1, in particular in the pancreatic tissue facilitates differentiation and regeneration of the ²-cells already present that are in need of repair. These repaired insulin producing cells can contribute to the correction and maintenance of normal physiological glycemic levels.
Patent DK-1284959-T3 (DK)
Inventor: MJALLI ADNAN
IPC: A61P43/00
Filed: 2001-05-25
Granted: 2005-11-21
Abstract: This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, ²-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction and tumor invasion and metastasis.
Patent DK-1417385-T3 (DK)
Inventor: HOJHOLT SUSANNE
IPC: E04B1/76
Filed: 2001-07-17
Granted: 2010-07-19
Abstract: A flexible panel (1) for heat- and sound-insulating the area between parallel beam elements arranged with an interspacing (x), eg. two ridge beams (3', 3'') of two trusses in a roof structure. The panel is made from mineral wool fibres and provided with planar end faces (6) cut off substantially perpendicular to the "flex" direction (A) of the panel. The length (1) of the panel (1) slightly exceeds the spacing (x) between the beam elements and its thickness (t) exceeds one cross-sectional dimension of the beam element, eg the height (h) of the ridge beams (3', 3''). At least one of the end faces (6) of the panel is provided with one to five slits provided substantially parallel to the large planar lateral faces of the panel. The distance (y) between one of said lateral faces (1b) and the first slit (5, 5a) in the row of slits (5a-5e) corresponds substantially to one cross-sectional dimension of the beam element, eg the height (h) of the ridge beam (3', 3'). As a result the panel may provide insulation between the beam element as well as above said elements in a more simple manner than hitherto known.
Patent DK-1366213-T3 (DK)
Inventor: MARTELLI GIAN NICOLA
IPC: C25B11/04
Filed: 2002-02-28
Granted: 2005-01-17
Abstract: An oxygen-depolarized cathode for aqueous hydrochloric acid electrolysis membrane cells is described, the cathode being in contact with the membrane and capable of preventing the release of hydrogen into oxygen even at the highest current densities. Hydrochloric acid may also be of technical grade with a concentration limited to 15%, whereas the operating temperature must not exceed 60° C. The cathode contains a mixture of rhodium sulphide and a metal of the platinum group applied in a single layer or alternatively applied separately in two distinct layers.
Patent DK-1436565-T3 (DK)
Inventor: JULSRUD STEIN
IPC: C04B35/462
Filed: 2002-09-25
Granted: 2008-03-10
Abstract: The present invention relates to a ceramic heat exchanger manufactured from an oxide material that is highly refractory and highly stable in a wide range of oxygen partial pressures and in the presence of certain gases and which is capable of operating at temperatures ranging from below 400 to well above 1300° C. for a prolonged period of time. The oxide material is represented by the formula: A1-xBxO(3+x+z)/2 where A is selected from the group consisting of La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y, and mixtures thereof, B represents Zr, Ti or Hf or mixtures thereof, x is greater than or equal to zero and less than or equal to one, and z is a number that renders the compound charge neutral and is greater than about -0.1 and less than about 0.2.
Patent DK-1438057-T3 (DK)
Inventor: TANAKA AKIKO
IPC: A61K39/39
Filed: 2002-09-26
Granted: 2011-02-07
Abstract: A method of producing a pine cone extract and the pine cone extract produced there from, wherein the pine cone extract is useful in increasing the effects of nucleic acid vaccines and medicaments; and useful in the production of phenotypically immature and/or mature dendritic and/or fibrocyte cells.
Patent DK-1488795-T3 (DK)
Inventor: BABA AKEMI
IPC: A61K45/06
Filed: 2003-03-17
Granted: 2012-05-07
Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.
Patent DK-1602026-T3 (DK)
Inventor: UNANDER TOMAS
IPC: G06F3/033
Filed: 2003-12-15
Granted: 2010-02-01
Abstract: A poster comprising a substrate ( 2 ), a layer of electrically conducting material applied in a pattern ( 3 ) on said substrate and a printed layer containing an image, wherein said pattern ( 3 ) includes a set of separate input areas ( 4 ) and connecting strips ( 5 ) leading form said input areas and a method for producing such an input device.
Patent DK-1842113-T3 (DK)
Inventor: ROBINSON JOHN
IPC: G01K3/04
Filed: 2006-01-20
Granted: 2011-11-28
Abstract: A time indicator label comprises a backing layer, an active layer and a barrier layer. Removal of said barrier layer activates said time indicator label.
Patent DK-1927699-T3 (DK)
Inventor: BERGHAUS PETER
IPC: E01F15/04
Filed: 2007-08-01
Granted: 2010-03-29
Abstract: Wall connectors (13) each have a connecting element (18), which fastens adjacent wall elements (10a,10b) on their end areas and has a locking element (20) to apply interlocking with a positive fit to the wall elements on their underside (24) crosswise to a traffic deflecting panel/wall.
Patent DK-1858243-T3 (DK)
Inventor: LEUNG JEFFREY C
IPC: A61L/
Filed: 2003-09-29
Granted: 2010-03-29
Abstract: This invention relates to a barbed suture for connecting human or animal tissue in combination with a surgical needle, said combination comprising a barbed suture attached to a surgical needle, wherein the suture comprises a plurality of barbs projecting from an elongated body having a first end and a diameter, each barb facing in a direction and being adapted for resisting movement of the suture when in tissue, in an opposite direction from the direction in which the barb faces, characterized in that the elongated has a non-circular diameter and the surgical needle has a diameter with a ratio of the surgical needle diameter to the barbed suture diameter of about 3:1 or less.
Patent DK-2226901-T3 (DK)
Inventor: CAPALDI-TALLON ALAN
IPC: H01R9/26
Filed: 2008-02-22
Granted: 2012-02-20
Abstract: Apparatus comprising an electrical terminal block (10) and an adaptor plate (50) having a planar web portion (51) integral with flanges (53) for fixture to an electrical housing (60) for the terminal block (10) and other electrical components, the electrical terminal block (10) having a base with four or more lugs (18a-18d, 19a-19d) projecting downwardly from a generally flat undersurface for locking the block against the adaptor plate (50) having edges which are co-planar in a plane parallel to the block's undersurface; 
at least two of the lugs (18a-18d) being formed with opposed channels (21a-21d), each open at one side for receiving and laterally abutting against one of two corresponding oppositely-extending edges of the adaptor plate so as to lock the block against the adaptor plate, at least two others of the lugs (19a-19d) being stops for laterally abutting corresponding edges of the adaptor plate; 
whereby the block may be fixed to the adaptor plate by resting its undersurface against the block and twisting it in the plane of the undersurface until all the lugs are in abutment against the corresponding edges; 
in which each stop lug is resiliently moveable upwardly, normal to the undersurface, when depressed, to reduce the extent of its projection from the undersurface; and 
the web portion having edges against which the lugs of the block may abut so that they lock the block to the adaptor plate.
Patent DK-2287305-T3 (DK)
Inventor: MCSWIGGEN JAMES
IPC: A61K31/713
Filed: 2003-02-20
Granted: 2015-03-09
Abstract: The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), doublestranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.
Patent DK-0406742-T3 (DK)
Inventor: HEITMANN WALTER
IPC: C07C27/02
Filed: 1990-06-30
Granted: 1993-05-17
Abstract: A process for the preparation of cis-dihydronopol and its esters is described. Corresponding esters of (-)-nopol are hydrogenated stereoselectively by heterogeneous hydrogenation in the presence of a platinum or platinum oxide catalyst or of a ruthenium/carbon catalyst and the cis-dihydronopyl esters obtained are, if desired, converted into the corresponding alcohol.
Patent DK-0428948-T3 (DK)
Inventor: DOERK HORST
IPC: F24F11/00
Filed: 1990-11-09
Granted: 1995-02-20
Abstract: The invention relates to a process for energy recovery from the air flow between the internal room air and the external air with fans 5, 6 which press the air through heat accumulators 3, 4 in mutually opposite flow directions, a heat accumulator 3, 4 and a fan 5, 6 working, mostly in opposite directions, in each of two mutually separated ducts 1, 2, and the directions of rotation of both fans 5, 6 changing simultaneously at regular intervals.
Patent DK-0431838-T3 (DK)
Inventor: RANGANATHAN RAMACHANDRAN S
IPC: C07D263/24
Filed: 1990-11-29
Granted: 1995-12-04
Abstract: New nonionic radiographic contrast agents having the formula <CHEM>  wherein Y is a single bond -CH2CH2-, -CH2O-, -OCH2-, <CHEM>   R1 and R2 are the same or different and are <CHEM>   <CHEM> R3 and R4 are the same or different and are hydrogen, methyl or -CH2CH2OH; R5 is hydrogen, alkyl, -CH2CH2OH, CH2OH or OH and R6 is alkyl, -CH2CH2OH, CH2OH, OH or hydrogen and may be the same or different than R5 and m is zero or one with the proviso that no methylene or methine carbon atom of the heterocyclic ring is attached to both a nitrogen and an oxygen atom with the additional proviso that when Y is a single bond then m is not zero. These new contrast agents are water soluble and have desirable low osmolality properties.
Patent DK-0434592-T3 (DK)
Inventor: KOK LIM JIU
IPC: G01N33/543
Filed: 1990-03-21
Granted: 1995-12-18
Abstract: The invention is an apparatus and method for performing the Western Blot Assay and other assays. The invention includes a tray (8) within which multiple samples can be assayed with a minimum of operator attention. The tray that is desirably used with the apparatus is multichambered [62-66] and can be alternately agitated and drained according to drive cards and/or other controls such as electronic controls [18]. The tray [8] is designed is such a way that reagents and washing fluids [90], which are added [9-12,37] sequentially and then claered, do not back flow into the chamber [62-66] of the tray. <IMAGE>
Patent DK-0490726-T3 (DK)
Inventor: LALLIER JEAN-PIERRE
IPC: C09D9/00
Filed: 1991-11-28
Granted: 1995-06-26
Abstract: Stripping composition comprising, by volume: 
 
  a) 1 to 20 % of an aprotic polar solvent chosen from the group consisting of: dimethyl sulphoxide, dimethylformamide, N-methylpyrrolidone, N-methylmorpholine,  gamma -butyrolactone, acetonitrile and mixtures thereof; and 
  b) 99 to 80 % of an ether chosen from the group consisting of: methyl tert-butyl ether, diethyl ether, tert-amyl methyl ether, tetrahydrofuran, dioxane and mixtures thereof. 
 
<??>This composition is useful for stripping paints, especially paints in the building sector.